EPHB2 and glioblastoma: Additionally, mutant EGFRvIII has been shown to suppress PDGFRβ expression via mTORC1- and ERK-dependent mechanisms and blocking such pathways de-repressed PDGFRβ signaling for growth and survival in glioblastomas [55].